NCT00983034View on ClinicalTrials.gov

The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

July 31, 2009

Conditions
Nephrotic SyndromeGlomerulonephritisMembranous Nephropathy
Interventions
DRUG

lansoprazole, amoxicillin, clarithromycin

lansoprazole, 30 mg twice daily, plus amoxicillin, 0.75 g twice daily, plus clarithromycin, 250 mg twice daily, for 14 days

Trial Locations (1)

34390

Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT00983034 - The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy | Biotech Hunter | Biotech Hunter